Removing Fibroids And Polyps To Improve Conception Odds

Uterine fibroids and endometrial polyps are usually benign growths, but their location and size can affect implantation, sperm transport, pregnancy maintenance, or uterine anatomy. Removing a growth can improve conception prospects most clearly when it distorts the uterine cavity—particularly a submucosal fibroid or a polyp identified during an infertility evaluation—although surgery does not guarantee pregnancy and may offer little benefit for symptom-free, non-cavity-distorting fibroids. The American Society for Reproductive Medicine (ASRM) reports that hysteroscopic removal of cavity-distorting fibroids may improve clinical pregnancy rates, while evidence is insufficient for routine removal of fibroids that do not affect the cavity. For polyps, randomized research in women undergoing intrauterine insemination found higher pregnancy rates after hysteroscopic polypectomy. Decisions should therefore combine imaging, age, ovarian reserve, sperm factors, duration of infertility, symptoms, and the planned fertility treatment.

Improve Conception Odds Through Fibroid and Polyp Removal

Fibroid and polyp removal for fertility is the targeted treatment of a uterine growth when its anatomical position or biological effects may reduce the chance of conception or a healthy pregnancy. Dr. William H. Parker’s clinical definition of uterine fibroids describes them as benign tumors arising from the uterine smooth muscle, whereas an endometrial polyp is an overgrowth of the lining of the uterus. In fertility care, the clinically important attribute is not simply whether a growth exists, but whether it changes the endometrial cavity, interferes with tubal openings, causes abnormal bleeding, or produces an inflammatory environment that could hinder implantation.

Fibroids are common: the National Institutes of Health notes that as many as 70% to 80% of women may develop them by age 50, although many cause no symptoms. Their fertility effects vary substantially. Polyps are also frequently found during infertility testing, but reported prevalence differs according to the population studied and the diagnostic method. Transvaginal ultrasound, saline-infusion sonography, hysterosalpingography, and hysteroscopy do not have identical accuracy, so an apparent polyp or fibroid may require confirmation before an operation.

Cavity-distorting fibroids and fertility

A cavity-distorting fibroid is a leiomyoma that projects into or substantially changes the endometrial cavity. The principal hyponym is the submucosal fibroid, classified in the International Federation of Gynecology and Obstetrics system as types 0, 1, or 2 according to how much of the lesion is within the cavity versus the uterine muscle. Some intramural fibroids, which grow within the uterine wall, can also distort the cavity or affect the uterine contour.

These lesions may reduce fertility by altering the implantation surface, disrupting local blood flow, changing uterine contractions, or interfering with sperm and embryo movement. Heavy menstrual bleeding, prolonged periods, pelvic pressure, and recurrent pregnancy loss can provide additional clues, but a woman may have no symptoms. ASRM’s 2017 guideline concluded that hysteroscopic myomectomy for submucosal fibroids improves clinical pregnancy rates. The same guideline found insufficient evidence to recommend removal of every non-cavity-distorting fibroid solely to improve fertility.

Non-cavity-distorting intramural and subserosal fibroids

Intramural fibroids are located within the muscular uterine wall, while subserosal fibroids grow toward the outer surface of the uterus. A large intramural fibroid may impair fertility even without obvious cavity distortion, but research has not established a universal size threshold at which surgery is beneficial. Subserosal fibroids generally have less direct effect on implantation because they do not grow into the endometrial cavity.

For this reason, routine myomectomy can expose a patient to operative bleeding, adhesions, infection, damage to surrounding organs, and a delay in trying to conceive without a proven fertility advantage. The decision becomes more individualized when a fibroid is large, rapidly enlarging, painful, associated with recurrent pregnancy loss, obstructs the cervix or fallopian tubes, or complicates access during egg retrieval or embryo transfer. A fertility specialist and gynecologic surgeon may compare expectant management, medical treatment for symptoms, hysteroscopic surgery, laparoscopic surgery, or abdominal myomectomy.

Endometrial polyps and implantation

An endometrial polyp is a localized overgrowth of endometrial glands, stroma, and blood vessels attached to the uterine lining by a stalk or broad base. Polyps may cause spotting between periods, bleeding after intercourse, heavy menstrual bleeding, or no symptoms at all. Their possible fertility effects include mechanical interference with sperm or embryo movement, local inflammation, and disruption of the normal implantation surface.

Hysteroscopic polypectomy is the standard fertility-directed procedure because it allows the clinician to see and remove the lesion through the cervix while preserving the surrounding endometrium. In a randomized study published in Fertility and Sterility, women with polyps scheduled for intrauterine insemination had a clinical pregnancy rate of approximately 51% after hysteroscopic removal compared with approximately 25% among women whose polyps were left in place. The result supports removal before IUI in appropriately selected patients, although it should not be interpreted as proof that every polyp must be removed before natural conception or in vitro fertilization.

Diagnose Fibroid and Polyp Location Before Choosing Surgery

Accurate diagnosis is the bridge between identifying a uterine growth and deciding whether removal is likely to improve conception odds. A standard transvaginal ultrasound can estimate size and location, but saline-infusion sonography often gives a clearer view of the cavity. Diagnostic hysteroscopy directly examines the lining and can sometimes combine diagnosis and treatment in the same procedure. Magnetic resonance imaging is useful when there are multiple fibroids, a very large uterus, uncertain anatomy, or concern about surgical planning.

Ultrasound, saline sonography, and hysteroscopy

Transvaginal ultrasound is usually the first-line test because it is widely available and does not use radiation. Saline-infusion sonography adds sterile fluid to expand the uterine cavity, making small polyps and submucosal fibroids easier to distinguish from thickened or irregular endometrium. Hysteroscopy remains the most direct method for inspecting the cavity and is particularly useful when bleeding, an abnormal scan, repeated implantation failure, or recurrent pregnancy loss raises concern.

A useful clinical comparison chart would place growth type, cavity involvement, typical procedure, and strength of fertility evidence in adjacent columns: submucosal fibroids generally have the clearest rationale for hysteroscopic removal; endometrial polyps often have a favorable removal-to-risk balance; intramural fibroids require individualized assessment; and subserosal fibroids are least likely to justify surgery for fertility alone.

Assess the whole fertility picture

Removing a uterine lesion cannot correct diminished ovarian reserve, ovulatory disorders, blocked fallopian tubes, severe endometriosis, or male-factor infertility. The evaluation should usually include ovulation history, ovarian reserve testing when appropriate, tubal assessment, and semen analysis. Age is especially important because egg quantity and quality decline over time; delaying treatment for surgery may be counterproductive when the lesion is unlikely to be the main cause of infertility.

The American College of Obstetricians and Gynecologists emphasizes that treatment selection depends on symptoms, size and location, reproductive plans, age, and overall health. A patient with a small, asymptomatic subserosal fibroid may reasonably proceed with fertility treatment, whereas a patient with a polyp filling the cavity or a type 0 submucosal fibroid may benefit from removal before attempting IUI or embryo transfer.

Select Removal Methods That Preserve Reproductive Potential

Hysteroscopic polypectomy and myomectomy

Hysteroscopic surgery uses a slender camera and instruments passed through the vagina and cervix, so there is no abdominal incision. It is commonly used for endometrial polyps and selected submucosal fibroids. Recovery is generally shorter than recovery from abdominal surgery, but risks include infection, bleeding, fluid-related complications, uterine perforation, incomplete removal, and intrauterine adhesions. Tissue is typically sent for pathology because most lesions are benign but diagnosis should be confirmed.

Laparoscopic and abdominal myomectomy

Laparoscopic or robotic myomectomy removes fibroids through small abdominal incisions, while abdominal myomectomy uses a larger incision and may be selected for numerous, very large, or deeply embedded fibroids. These operations can preserve the uterus but may create scar tissue, and the uterine wall may need time to heal before pregnancy. Depending on the depth of the incision, number of fibroids, and surgeon’s assessment, a planned cesarean birth may be discussed in a future pregnancy.

Uterine artery embolization and radiofrequency ablation can reduce fibroid size and bleeding, but their roles are different from fertility-directed myomectomy. Because reproductive outcomes after these treatments remain less established and may involve effects on the uterine lining or pregnancy, people actively pursuing pregnancy should discuss alternatives with a reproductive endocrinologist before choosing them.

Time Conception Attempts After Fibroid and Polyp Removal

The interval before trying to conceive depends on the procedure, depth of uterine repair, healing progress, and the fertility plan. After uncomplicated hysteroscopic polypectomy, a clinician may permit attempts after the next menstrual cycle or another individualized interval. Recovery after myomectomy is longer, especially when the uterine muscle was extensively incised. There is no single waiting period that applies to all patients.

Follow-up imaging may be appropriate when a lesion was large, removal was incomplete, symptoms continue, or assisted reproduction is planned. Patients should seek prompt medical attention for fever, severe pain, heavy bleeding, foul-smelling discharge, fainting, or shortness of breath after surgery. Pregnancy planning should also include folic acid, medication review, anemia treatment when needed, and a discussion of how prior uterine surgery affects prenatal monitoring and delivery planning.

Conclusion: Match Fibroid and Polyp Removal to the Fertility Problem

Fibroid and polyp removal can improve conception odds when a growth distorts the uterine cavity or creates a plausible barrier to implantation. The strongest evidence supports hysteroscopic treatment for cavity-distorting submucosal fibroids and supports polypectomy in selected infertility patients, including those preparing for IUI. Evidence is weaker for removing asymptomatic intramural or subserosal fibroids that do not change the cavity, making individualized counseling essential.

The next practical step is a fertility-focused evaluation that confirms the growth’s type, size, and location while assessing ovulation, tubes, sperm, ovarian reserve, and age-related factors. Patients should ask whether surgery is expected to improve live-birth chances, what alternatives exist, how long treatment will delay conception, and how the procedure may affect pregnancy or delivery. A reproductive endocrinologist and an experienced gynecologic surgeon can help balance potential benefit against operative risk.

Sources: American Society for Reproductive Medicine, Removal of Myomas in Asymptomatic Patients to Improve Fertility and/or Reduce Miscarriage Rate, https://www.asrm.org/practice-guidance/practice-committee-documents/removal-of-myomas-in-asymptomatic-patients-to-improve-fertility-andor-reduce-miscarriage-rate-2017/; American College of Obstetricians and Gynecologists, Uterine Fibroids, https://www.acog.org/womens-health/faqs/uterine-fibroids; National Institutes of Health, Uterine Fibroids, https://www.nichd.nih.gov/health/topics/uterine; Perez-Medina, T. et al., “Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination,” Fertility and Sterility, 2005, https://pubmed.ncbi.nlm.nih.gov/15705364/; International Federation of Gynecology and Obstetrics, FIGO Leiomyoma Subclassification System, https://www.figo.org/news/figo-classification-system-uterine-leiomyomas; Parker, W. H., “Etiology, symptomatology, and diagnosis of uterine myomas,” Fertility and Sterility, https://pubmed.ncbi.nlm.nih.gov/15705363/